The deletion of the C-terminal tail and addition of an endoplasmic reticulum targeting signal to Alzheimer's amyloid precursor protein change its localization, secretion, and intracellular proteolysis

被引:21
|
作者
Kouchi, Z
Kinouchi, T
Sorimachi, H
Ishiura, S
Suzuki, K
机构
[1] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, Tokyo 1538902, Japan
[2] Univ Tokyo, Inst Mol & Cellular Biosci, Lab Mol Struct & Funct, Tokyo, Japan
[3] Jichi Med Sch, Dept Biochem, Minamikawachi, Tochigi, Japan
来源
EUROPEAN JOURNAL OF BIOCHEMISTRY | 1998年 / 258卷 / 02期
关键词
Alzheimer's disease; amyloid precursor protein; sorting; ER retrieval signal; proteolysis;
D O I
10.1046/j.1432-1327.1998.2580291.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The metabolic pathway of Alzheimer's amyloid precursor protein (APP) involves restricted intracellular proteolysis by secretases, which leads to the secretion of the N-terminal soluble APP (sAPP) and the generation of a cell-associated C-terminal fragment. The precise cellular sites at which these processes occur remain unknown. In this report, we describe the route of APP sorting and the processing site using novel systems with and without sorting signals on the APP molecule. One system involves the replacement of the C-terminal ten amino acids of APP with Adenoviral E19 protein containing an endoplasmic reticulum (ER) retrieval signal (APPE19); the other involves deleting the last ten amino acids correponding to the replaced site (APPdeltaC10). APPE19 localized mainly within the cis/medial Golgi compartment and exclusively suppresses the secretion of APP. In contrast, deletion of the C-terminal tail promotes sAPP secretion by a constitutive secretion pathway. Metabolic labeling followed by immunoprecipitation with anti-APP antibody revealed that APPE19 is rapidly degraded within 30 min and that the subsequent intracellular turnover rate is decreased with 40% of the protein retained within the cells even after a chase period a 3 h. In contrast, APPdeltaC10 is rapidly eliminated from the intracellular compartments and secreted into the culture medium. The surface internalization and recycling processes of this protein are relatively impaired compared with wild-type APP. The ratios of the levels of production to secretion of sAPP alpha, the N-terminal, soluble APP fragment released by alpha-secretase, are proportional to the secretion efficiencies among APP species, suggesting the localization of alpha-secretase within a compartment late in the constitutive secretion pathway. These secretion mutants which utilize ER targeting signals are useful tools for analyzing the location of secretases and the intracellular degradation system within a constitutive secretion pathway such as ER quality control.
引用
收藏
页码:291 / 300
页数:10
相关论文
共 27 条
  • [21] Accumulation of amyloid precursor protein C-terminal fragments triggers mitochondrial structure, function, and mitophagy defects in Alzheimer's disease models and human brains
    Vaillant-Beuchot, Loan
    Mary, Arnaud
    Pardossi-Piquard, Raphaelle
    Bourgeois, Alexandre
    Lauritzen, Inger
    Eysert, Fanny
    Kinoshita, Paula Fernanda
    Cazareth, Julie
    Badot, Celine
    Fragaki, Konstantina
    Bussiere, Renaud
    Martin, Cecile
    Mary, Rosanna
    Bauer, Charlotte
    Pagnotta, Sophie
    Paquis-Flucklinger, Veronique
    Buee-Scherrer, Valerie
    Buee, Luc
    Lacas-Gervais, Sandra
    Checler, Frederic
    Chami, Mounia
    ACTA NEUROPATHOLOGICA, 2021, 141 (01) : 39 - 65
  • [22] Cyclic AMP inhibition of tumor necrosis factor α production induced by amyloidogenic C-terminal peptide of Alzheimer's amyloid precursor protein in macrophages:: Involvement of multiple intracellular pathways and cyclic AMP response element binding protein
    Chong, YH
    Shin, YJ
    Suh, YH
    MOLECULAR PHARMACOLOGY, 2003, 63 (03) : 690 - 698
  • [23] Self-oligomerization of NACP, the precursor protein of the non-amyloid β/A4 protein (Aβ) component of Alzheimer's disease amyloid, observed in the presence of a C-terminal Aβ fragment (residues 25-35)
    Paik, SR
    Lee, JH
    Kim, DH
    Chang, CS
    Kim, YS
    FEBS LETTERS, 1998, 421 (01) : 73 - 76
  • [24] A C-terminal peptide from secreted amyloid precursor protein-α enhances long-term potentiation in rats and a transgenic mouse model of Alzheimer's disease
    Morrissey, Jodi A.
    Mockett, Bruce G.
    Singh, Anurag
    Kweon, David
    Ohline, Shane M.
    Tate, Warren P.
    Hughes, Stephanie M.
    Abraham, Wickliffe C.
    NEUROPHARMACOLOGY, 2019, 157
  • [25] Molecular mechanisms underlying cyclic AMP inhibition of macrophage dependent TNF-α production and neurotoxicity in response to amyloidogenic C-terminal fragment of Alzheimer's amyloid precursor protein
    Chong, YH
    Shin, SA
    Lee, HJ
    Kang, JHL
    Suh, YH
    JOURNAL OF NEUROIMMUNOLOGY, 2002, 133 (1-2) : 160 - 174
  • [26] Signal transduction through tyrosine-phosphorylated C-terminal fragments of amyloid precursor protein via an enhanced interaction with Shc/Grb2 adaptor proteins in reactive astrocytes of Alzheimer's disease brain
    Russo, C
    Dolcini, V
    Salis, S
    Venezia, V
    Zambrano, N
    Russo, T
    Schettini, G
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (38) : 35282 - 35288
  • [27] The cytoplasmic domain of Alzheimer's amyloid-β protein precursor causes sustained apoptosis signal-regulating kinase 1/c-Jun NH2-terminal kinase-mediated neurotoxic signal via dimerization
    Hashimoto, Y
    Niikura, T
    Chiba, T
    Tsukamoto, E
    Kadowaki, H
    Nishitoh, H
    Yamagishi, Y
    Ishizaka, M
    Yamada, M
    Nawa, M
    Terashita, K
    Aiso, S
    Ichijo, H
    Nishimoto, I
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 306 (03): : 889 - 902